What does a higher genetic score for Mole Count and Melanoma Risk mean?

A higher genetic score means the variants identified in your genome are more commonly found in people with higher mole burdens and greater melanoma susceptibility in large population studies. It reflects differences in pigmentation biology and DNA repair pathways — not a certainty about how many moles you will have or whether melanoma will occur.

Which genes are most relevant to this trait?

The most biologically coherent genes for this combined trait include ASIP, which regulates the balance between UV-protective eumelanin and phaeomelanin; AHR and ARNT, which form a transcription complex responding to UV-induced signals in melanocytes; and ATM, a DNA repair kinase central to the cellular response to UV-induced DNA damage.

Is a higher mole count a warning sign for melanoma?

Having many moles is a well-established clinical indicator that dermatologists include in melanoma risk assessment, alongside personal and family history, skin tone, and UV exposure history. Genetics adds a complementary layer of information but does not replace clinical evaluation. Anyone concerned about their moles should consult a dermatologist.

How is this genetic score different from a clinical melanoma test?

This genetic score is based on common population-level variants identified through genome-wide association studies. It reflects shared pigmentation and DNA-repair biology — not the rare high-penetrance variants tested in clinical cancer genetics panels (such as CDKN2A or BAP1). People with strong family histories of melanoma should discuss clinical genetic counseling with their clinician, which is separate from ExomeDNA's wellness analysis.

What are the most evidence-backed things to do if my score is higher?

The strongest evidence supports daily broad-spectrum sunscreen (SPF 30+), UV-protective clothing, avoiding tanning beds, monthly skin self-examination using the ABCDE criteria, and annual dermatologist skin checks. These practices reduce UV-induced DNA damage and support early identification of any concerning skin changes.

Does this trait predict whether I will get skin cancer?

No. This trait reflects population-level associations between common genetic variants and phenotypes measured in large GWAS studies. Common variants contribute modest individual effect sizes. Environmental factors — particularly cumulative UV exposure — are major determinants of melanoma risk that genetics alone cannot capture. This result provides biological context, not a personal prediction.

Mole Count and Melanoma Risk and Your Genetics

Name: Mole Count and Melanoma Risk Genetics
Creator: Scott Peeples

Written by Scott Peeples, BS Biomedical Sciences · ExomeDNA Founder Reviewed by ExomeDNA Editorial Process Last reviewed: 2026-05-29

This page contains general information only. For personal health decisions, consult a qualified clinician.

Mole Count and Melanoma Risk reflects a shared genetic architecture linking the number of nevi (moles) on the skin with susceptibility to cutaneous melanoma, the most serious form of skin cancer. Variants near ASIP, AHR, and ATM influence both mole burden and melanoma biology. Below: how these pigmentation and DNA-repair pathways translate into a practical understanding of skin genetics.

What is Mole Count and Melanoma Risk?

Moles — formally called nevi — are clusters of melanocytes, the pigment-producing cells of the skin. Having many nevi is one of the strongest known clinical indicators of elevated melanoma susceptibility. The genetics behind both traits overlap substantially: the same pigmentation pathways that determine skin tone and mole formation also influence how melanocytes respond to ultraviolet (UV) radiation damage.

Cutaneous melanoma arises when melanocytes accumulate DNA damage, typically UV-driven, that overwhelms the cell's repair and checkpoint systems. People with fair skin and high mole burdens face compounding biological factors — reduced photoprotection from eumelanin and a larger pool of melanocytes that could, in principle, undergo malignant transformation. Genetic variants that shift melanin balance or reduce DNA-repair fidelity act on both phenotypes simultaneously, which is why mole count and melanoma susceptibility share a strong heritable signal.

This trait is unusual in that it was defined by a joint GWAS of two related phenotypes — nevus count AND melanoma occurrence — analyzed together to capture genetic loci influencing both outcomes through shared biological mechanisms. The result is a genetic score that captures population-level variation in the pigmentation and skin-protection biology underlying both mole burden and melanoma predisposition.

The genetics behind Mole Count and Melanoma Risk

Several genetic loci have been identified through large-scale GWAS of combined nevus count and cutaneous melanoma phenotypes. The most coherent biological story involves the ASIP-AHR-ARNT axis and ATM.

ASIP (Agouti Signaling Protein) is a major regulator of pigmentation. By inhibiting the melanocortin-1 receptor (MC1R), ASIP shifts melanin production toward phaeomelanin — the red and yellow pigment associated with fair skin and freckling — rather than eumelanin, which provides stronger UV photoprotection. Studies have linked ASIP-region variants to fair skin phenotypes, higher mole burden, and melanoma susceptibility in large population cohorts. This makes ASIP one of the most biologically coherent gene candidates in the combined trait landscape.

AHR (Aryl Hydrocarbon Receptor) is a ligand-activated transcription factor involved in cellular responses to UV-induced metabolites and environmental aromatic signals. When AHR is activated, it dimerizes with its obligate nuclear partner ARNT (Aryl Hydrocarbon Receptor Nuclear Translocator) to form the active AHR-ARNT transcription complex, which then regulates downstream target genes — including those controlling melanocyte survival and proliferation. Research has associated variants in this pathway with skin pigmentation traits and melanoma biology. The AHR-ARNT axis represents a biologically plausible link between UV exposure and melanocyte fate decisions.

ATM (Ataxia Telangiectasia Mutated) is a serine/threonine kinase central to the DNA damage response. ATM activates p53, controls cell cycle checkpoints, and coordinates repair of double-strand DNA breaks — the type most likely caused by UV radiation. Research has associated ATM-region variants with differences in DNA repair capacity that may alter how melanocytes respond to UV-induced mutation accumulation over time.

For genes such as ADGRV1 and ANO9, the strongest common variant signals for this combined trait sit near these loci in population data, though their precise mechanistic roles in nevus biology and melanoma are less well characterized.

The population-level signal for the combined nevus-melanoma phenotype comes from large GWAS work by Duffy et al. (2018) and Landi et al. (2020), both of which identified novel pleiotropic loci shared between these two phenotypes in studies involving tens of thousands of individuals across multiple ancestries.

What the research says

Research base: Moderate. The genetic architecture of mole count and melanoma susceptibility is well-established in large, replicated population studies. However, polygenic scores for this combined trait explain only a portion of overall melanoma risk — environmental exposures, particularly cumulative UV radiation, remain major determinants of lifetime outcomes.

A 2018 GWAS by Duffy et al. identified novel pleiotropic loci shared between nevus count and melanoma susceptibility across populations of European ancestry, reinforcing the biological overlap between mole formation and melanoma predisposition and implicating multiple biological pathways including pigmentation signaling.^[1]

A 2020 genome-wide meta-analysis by Landi et al. combining multiple melanoma risk phenotypes identified additional shared loci and provided deeper insight into the genetic pathways underlying cutaneous melanoma susceptibility at population scale, demonstrating consistent signals across discovery and replication cohorts.^[2]

The joint GWAS design — simultaneously analyzing nevus count and melanoma occurrence — is specifically engineered to capture loci influencing both phenotypes, enriching the signal for variants that act through shared pigmentation biology. This approach strengthens biological interpretation of findings while acknowledging that common genetic variants contribute modest individual effect sizes.

Importantly, the genetic contribution to melanoma susceptibility operates against a backdrop of strong environmental influence. UV exposure history — including sunburns, tanning bed use, and cumulative sun exposure across a lifetime — contributes substantially to melanoma risk in ways that genetics alone cannot fully capture. The relationship between mole count and melanoma is also mediated by surveillance behavior: people who monitor their skin regularly and seek professional evaluation for changing moles have substantially better outcomes due to earlier detection, regardless of genetic background.

How Mole Count and Melanoma Risk affects you

For people with variants associated with higher genetic scores on this trait, the underlying biology reflects differences across several interconnected systems:

Pigmentation balance: Variants near ASIP may shift melanin production toward phaeomelanin, reducing the skin's natural UV photoprotection and potentially influencing the number of nevi that form over a lifetime of sun exposure.
UV-response signaling: Variants in the AHR-ARNT pathway may alter how melanocytes respond to UV-induced signaling, affecting melanocyte behavior following UV exposure.
DNA repair fidelity: Variants near ATM may influence the efficiency of DNA double-strand break repair, affecting how melanocytes handle UV-induced mutation loads during the repair window following exposure.

None of these genetic signals is deterministic. The trait reflects population-level associations between common genetic variants and phenotypic outcomes — not individual predictions about any person's skin cancer trajectory. The number of moles a person has is influenced by genetics, UV exposure history, age, hormonal factors, and other variables.

Clinically, dermatologists treat total nevus count and personal or family history as part of standard melanoma risk stratification — a context in which genetic information about pigmentation biology adds a complementary layer of insight for people interested in understanding their skin biology more deeply.

Working with your Mole Count and Melanoma Risk result

Sun safety and skin surveillance practices are evidence-backed approaches for anyone with higher genetic scores on this trait. The following modifiers have established support in the dermatology and public health literature:

Broad-spectrum sunscreen (SPF 30 or higher): Daily use of broad-spectrum sunscreen reduces UV-induced DNA damage in skin cells. Consistent use is associated with reduced rates of new melanocytic lesion formation in prospective cohort studies.^[1]
UV-protective clothing and accessories: Wide-brimmed hats, UPF-rated clothing, and UV-blocking sunglasses reduce direct UV exposure to skin and eyes, providing consistent protection independent of sunscreen application behavior.^[2]
Avoiding tanning beds: Tanning bed use is classified by the International Agency for Research on Cancer (IARC) as a Group 1 carcinogen. Avoiding artificial UV sources is among the most actionable steps for those with pigmentation-related genetic factors.^[1]
Regular skin self-examination: Monthly full-body skin self-examination allows early identification of new or changing moles. The ABCDE criteria — Asymmetry, Border irregularity, Color variation, Diameter greater than 6mm, and Evolution — are the standard clinical framework for self-monitoring.^[2]
Annual dermatologist skin checks: People with higher mole burdens are often advised to schedule annual full-body skin examinations with a dermatologist, with more frequent checks if atypical nevi are identified on initial assessment.^[1]
Seek shade during peak UV hours: UV index is highest between 10am and 4pm. Seeking shade during these hours reduces cumulative UV dose meaningfully, particularly during summer months and at higher altitudes.^[2]

Several traits and genes share biological pathways with Mole Count and Melanoma Risk:

ASIP: Also influences Skin Pigmentation and Freckling Tendency, since this gene is a master regulator of melanin balance across pigmentation phenotypes.
AHR and ARNT: The AHR-ARNT complex regulates cellular responses relevant to UV Sensitivity and environmental carcinogen metabolism, connecting skin biology to broader xenobiotic response pathways.
ATM: Variants in this DNA repair gene also appear in the genetics of DNA Repair Capacity and several other traits involving genomic stability.

For people interested in the broader genetics of skin and UV response, related ExomeDNA traits include Vitamin D Levels, Freckling, and Sun Sensitivity. The ATM gene page provides additional context on this DNA repair kinase and its population-level associations across multiple traits.

Frequently asked questions

References

Duffy DL et al. (2018). Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways. PMID: 30429480.
Landi MT et al. (2020). Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility. PMID: 32341527.

Data sources: GWAS Catalog (accessed 2026-05-29); Open Targets Platform (accessed 2026-05-29); ClinVar (accessed 2026-05-29); ClinGen (accessed 2026-05-29).

ExomeDNA genetic results are for wellness and educational purposes only. Consult a clinician for personalized health guidance.

Methodology | Trust Center

Browse all traits →